Data on the hemostasis in epistaxis with Topically Administered TXA Versus Topical Oxymetazoline Spray

• Main Authors: Kristen Whitworth, Jacob Johnson, Samuel Wisniewski, Meghan Schrader
• Format: Article
• Language: English
• Published: Elsevier 2020-04-01
• Series: Data in Brief
• Online Access: http://www.sciencedirect.com/science/article/pii/S2352340920301773

The use of tranexamic acid (TXA) has recently gained popularity as a treatment modality for epistaxis in the emergency department. Data are presented on the efficacy of the topical use of the intravenous formulation of TXA versus the vasoconstrictor oxymetazoline applied topically in achieving hemostasis in patient presenting to the emergency department with anterior epistaxis. The original article “Comparative Effectiveness of Topically Administered TXA Versus Topical Oxymetazoline Spray for Achieving Hemostasis in Epistaxis” [1] provides complete interpretation of the data. The dataset regarding these treatment modalities has clinical significance toward preventing an avoidable need for escalation of treatment that could potentially increase patient discomfort and prolong emergency department throughput time. Keywords: TXA, Tranexamic acid, Epistaxis, Oxymetazoline